menu
    • menu

    Company profile for TG ImmunoPharma

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TG ImmunoPharma (TGI) is a fast-growing biotech company established in Oct 2020 in Hefei, China. The team focuses on the discovery of novel targets and the development of antibodies or their analogs including BsAb, TsAb, and Immunocytokine to harness the body's immune system such as NK cells and other innate killer cells in the frontline against tumor. Based on the research of NK cell receptors and their ligands on tumors, and...
    TG ImmunoPharma (TGI) is a fast-growing biotech company established in Oct 2020 in Hefei, China. The team focuses on the discovery of novel targets and the development of antibodies or their analogs including BsAb, TsAb, and Immunocytokine to harness the body's immune system such as NK cells and other innate killer cells in the frontline against tumor. Based on the research of NK cell receptors and their ligands on tumors, and preclinical therapeutic studies by our investigators for more than 20 years, TGI is dedicated to becoming an international leading company aiming at restoring or renormalizing immunity against tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TG ImmunoPharmaChina Flag
    Country
    Country
    China
    Address
    Address
    #6 Intelligent Science and Technology Park, Jingkai District, Hefei, Anhui
    Telephone
    Telephone
    +86 0551-62862306
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tgimmunopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TG ImmunoPharma Announces FDA Clearance for Trial of TGI-6 Bispecific Antibody
    TG ImmunoPharma Announces FDA Clearance for Trial of TGI-6 Bispecific Antibody

    19 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tg-immunopharma-announces-fda-clearance-for-clinical-trial-of-tgi-6-bispecific-antibody-301853090.html

    PR NEWSWIRE
    19 Jun 2023
    Share Share
    TG ImmunoPharma Announces FDA Clearance for Trial of TGI-6 Bispecific Antibody
    TG ImmunoPharma Announces FDA Clearance for Trial of TGI-6 Bispecific Antibody

    16 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tg-immunopharma-announces-fda-clearance-for-clinical-trial-of-tgi-6-bispecific-antibody-301853097.html

    PR NEWSWIRE
    16 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search